Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis (Q45161924)

10 December 2017

title

Administration of 2-arachidonoylglycerol ameliorates both acute and chronic experimental autoimmune encephalomyelitis (English)

1 reference

10 December 2017

main subject

glyceryl 2-arachidonate

0 references

animal disease model

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21406188

27 November 2024

12

Raphael Mechoulam

1 reference

10 December 2017

author name string

Athanasios Lourbopoulos

1

1 reference

10 December 2017

Nikolaos Grigoriadis

2

1 reference

10 December 2017

Roza Lagoudaki

3

1 reference

10 December 2017

Olga Touloumi

4

1 reference

10 December 2017

Eleni Polyzoidou

5

1 reference

10 December 2017

Ioannis Mavromatis

6

1 reference

10 December 2017

Nikolaos Tascos

7

1 reference

10 December 2017

Aviva Breuer

8

1 reference

10 December 2017

Haim Ovadia

9

1 reference

10 December 2017

Dimitris Karussis

10

1 reference

10 December 2017

Ester Shohami

11

1 reference

10 December 2017

Constantina Simeonidou

13

1 reference

10 December 2017

language of work or name

English

0 references

publication date

13 March 2011

1 reference

full work available at URL

10 December 2017

https://api.elsevier.com/content/article/PII:S0006899311005178?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

https://api.elsevier.com/content/article/PII:S0006899311005178?httpAccept=text/plain

27 November 2024

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

27 November 2024

1 reference

10 December 2017

volume

1390

1 reference

10 December 2017

page(s)

126-141

1 reference

Microglia in neuroregeneration

10 December 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

CB2 cannabinoid receptors as an emerging target for demyelinating diseases: from neuroimmune interactions to cell replacement strategies

27 November 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.

27 November 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Endocannabinoids control spasticity in a multiple sclerosis model

27 November 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

27 November 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Cannabinoid CB2 receptors in human brain inflammation

27 November 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis

27 November 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Cannabinoid receptors and the regulation of immune response

27 November 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Development of microglia in the cerebral white matter of the human fetus and infant

27 November 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis

27 November 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Changes in CB1 receptors in motor-related brain structures of chronic relapsing experimental allergic encephalomyelitis mice

27 November 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Differential expression of the CB2 cannabinoid receptor by rodent macrophages and macrophage-like cells in relation to cell activation

27 November 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Cultured rat microglial cells synthesize the endocannabinoid 2-arachidonylglycerol, which increases proliferation via a CB2 receptor-dependent mechanism

27 November 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis

27 November 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

The endocannabinoid system in targeting inflammatory neurodegenerative diseases

27 November 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Heterogeneity of microglial activation in the innate immune response in the brain

27 November 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Brain cannabinoid systems as targets for the therapy of neurological disorders

27 November 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Non-CB1, non-CB2 receptors for endocannabinoids, plant cannabinoids, and synthetic cannabimimetics: focus on G-protein-coupled receptors and transient receptor potential channels

27 November 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Isolation and structure of a brain constituent that binds to the cannabinoid receptor

27 November 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation

27 November 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Transplanted neural precursor cells reduce brain inflammation to attenuate chronic experimental autoimmune encephalomyelitis

27 November 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Statistical analysis of data from studies on experimental autoimmune encephalomyelitis

27 November 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility.

27 November 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

2-Arachidonylglycerol, an endogenous cannabinoid, inhibits tumor necrosis factor-alpha production in murine macrophages, and in mice

27 November 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Cannabinoid CB2 receptors: Immunohistochemical localization in rat brain

27 November 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Axonal damage in multiple sclerosis: a complex issue in a complex disease

27 November 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction

27 November 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!

27 November 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Control of the cell survival/death decision by cannabinoids

27 November 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Cannabinoids and cell fate.

27 November 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus

27 November 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Amelioration of autoimmune neuroinflammation by recombinant human alpha-fetoprotein

27 November 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

2-Arachidonoyl-glycerol suppresses interferon-gamma production in phorbol ester/ionomycin-activated mouse splenocytes independent of CB1 or CB2.

27 November 2024

34

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

The cannabinoid system and immune modulation

27 November 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells.

27 November 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury

27 November 2024

37

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Effects of putative cannabinoid receptor ligands, anandamide and 2-arachidonyl-glycerol, on immune function in B6C3F1 mouse splenocytes

27 November 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells

27 November 2024

40

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

27 November 2024

41

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors

27 November 2024

42

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Cannabinoids and brain injury: therapeutic implications

27 November 2024

43

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Endocannabinoids and traumatic brain injury

27 November 2024

44

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Molecular characterization of a peripheral receptor for cannabinoids

27 November 2024

45

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Protective effects of microglia in multiple sclerosis.

27 November 2024

47

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Molecular mechanisms of axonal damage in inflammatory central nervous system diseases

27 November 2024

48

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Phagocytosis of apoptotic lymphocytes by oligodendrocytes in experimental autoimmune encephalomyelitis

27 November 2024

49

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis.

27 November 2024

50

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain

27 November 2024

51

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Suppression of interleukin-2 by the putative endogenous cannabinoid 2-arachidonyl-glycerol is mediated through down-regulation of the nuclear factor of activated T cells

27 November 2024

52

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Endocannabinoids and immune regulation

27 November 2024

53

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

27 November 2024

54

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition

27 November 2024

55

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Apoptosis of inflammatory cells in immune control of the nervous system: role of glia

27 November 2024

56

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Treating autoimmune demyelination by augmenting lymphocyte apoptosis in the central nervous system

27 November 2024

57

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

27 November 2024

58

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Receptors and channels targeted by synthetic cannabinoid receptor agonists and antagonists

27 November 2024

59

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors

27 November 2024

60

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.

27 November 2024

61

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Cannabinoids and neuroprotection in basal ganglia disorders.

27 November 2024

62

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

R-(+)-[2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: Partial involvement of the

27 November 2024

63

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Physiological mechanisms of lysophosphatidylcholine-induced de-ramification of murine microglia

27 November 2024

64

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Multiple sclerosis may disrupt endocannabinoid brain protection mechanism

27 November 2024

66

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Phagocytic properties of microglia in vitro: implications for a role in multiple sclerosis and EAE.

27 November 2024

67

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain

27 November 2024

68

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells

27 November 2024

69

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

New perspectives in the studies on endocannabinoid and cannabis: 2-arachidonoylglycerol as a possible novel mediator of inflammation

27 November 2024

70

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Pathogenesis of tissue injury in MS lesions

27 November 2024

72

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Identification and functional characterization of brainstem cannabinoid CB2 receptors

27 November 2024

73

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy

27 November 2024

74

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Ramification of microglia, monocytes and macrophages in vitro: influences of various epithelial and mesenchymal cells and their conditioned media

27 November 2024

75

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

P2X7 receptors control 2-arachidonoylglycerol production by microglial cells

27 November 2024

76

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Endocannabinoids accumulate in spinal cord of SOD1 G93A transgenic mice.

27 November 2024

77

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection

27 November 2024

78

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis

27 November 2024

79

1 reference

https://api.crossref.org/works/10.1016/J.BRAINRES.2011.03.020

27 November 2024

Identifiers

1 reference

10 December 2017

1 reference